-
, including animal studies and analyses of human tissue samples. This full-stack methodology enables us to directly link molecular channel function with disease phenotypes. The postdoctoral fellow will work
-
, you will engineer synthetic promoters controlling context-specific gene expression in Arabidopsis. You will develop high-throughput (molecular) phenotyping methods to screen transcriptional activity
-
support is available at VIB for those interested in applying for competitive postdoctoral fellowships, and such applications are actively encouraged. How to apply? Submit your application through the VIB
-
and ultimately accelerate these activities to combat climate change. Our approach combines science and engineering, beginning with the study of fundamental microbial metabolic processes that can be
-
-resistant forms. By identifying the biochemical factors that govern carbon storage in the ocean, we hope to better assess the impact of human activities on this reservoir and provide transferable results
-
) will not be taken into account. Your research qualities are in line with the faculty and university research policies . Your teaching competences are in line with the University of Antwerp’s educational
-
scientist will occupy a key position in the collaborative project, being (1) responsible to launch and conduct groundbreaking science within the project, (2) active at both the partners labs and (3) involved
-
, and predict their impact on species-specific properties of human neurons. This highly multidisciplinary project will be undertaken in active collaboration with our two labs, at a unique interface of top
-
application includes: A detailed CV A one-page summary of past research activities (e.g. in PhD/PostDoc projects) A one-page letter of intent describing your motivation for this position, how your research
-
actively seeking a postdoctoral bio-informatician to advance the liquid biopsy research in the team. An important aim in TOBI is the development of novel assays for diagnosis and monitoring cancer patients